Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States

IMPORTANCE: The antifungal medication voriconazole is used to prevent and treat aspergillosis, a major cause of mortality among recipients of lung transplants (hereinafter referred to as lung recipients). Small studies suggest that voriconazole increases risk of cutaneous squamous cell carcinoma (SC...

詳細記述

保存先:
書誌詳細
出版年:JAMA Dermatol
主要な著者: D’Arcy, Monica E., Pfeiffer, Ruth M., Rivera, Donna R., Hess, Gregory P., Cahoon, Elizabeth K., Arron, Sarah T., Brownell, Isaac, Cowen, Edward W., Israni, Ajay K., Triplette, Matthew A., Yanik, Elizabeth L., Engels, Eric A.
フォーマット: Artigo
言語:Inglês
出版事項: American Medical Association 2020
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7221851/
https://ncbi.nlm.nih.gov/pubmed/32401271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2020.1141
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料